scholarly journals Early Risk Factors for Obesity in the First 1000 Days—Relationship with Body Fat and BMI at 2 Years

2021 ◽  
Vol 18 (15) ◽  
pp. 8179
Author(s):  
Mercedes Díaz-Rodríguez ◽  
Celia Pérez-Muñoz ◽  
Jesús Carretero-Bravo ◽  
Catalina Ruíz-Ruíz ◽  
Manuel Serrano-Santamaría ◽  
...  
Keyword(s):  
Risk Factors ◽  
Weight Gain ◽  
Body Fat ◽  
Early Pregnancy ◽  
Body Fat Percentage ◽  
Z Score ◽  
Fat Percentage ◽  
Early Risk ◽  
Early Risk Factors ◽  
Increased Risk

(1) Background: Obesity is defined as an excessive accumulation of body fat. Several early developmental factors have been identified which are associated with an increased risk of childhood obesity and increased adiposity in childhood. The primary objective of the present study is to analyse the effect of various early risk factors on Body Mass Index (BMI) and body fat percentage at 2 years of age. (2) Methods: A prospective cohort study design was used, with the sample consisting of 109 mother-child pairs from whom data were collected between early pregnancy and 2 years old. Adiposity was determined based on skinfold measurements using the Brooks and Siri formulae. Mean comparison tests (Student’s t-test and ANOVAs) and multiple linear regression models were used to analyse the relationship between early programming factors and dependent variables. (3) Results: Maternal excess weight during early pregnancy (β = 0.203, p = 0.026), gestational smoking (β = 0.192, p = 0.036), and accelerated weight gain in the first 2 years (β = − 0.269, p = 0.004) were significantly associated with high body fat percentage. Pre-pregnancy BMI and accelerated weight gain in the first 2 years were associated with high BMI z-score (β = 0.174, p = 0.047 and β = 0.417, p = 0.000 respectively). The cumulative effect of these variables resulted in high values compared to the baseline zero-factor group, with significant differences in BMI z-score (F = 8.640, p = 0.000) and body fat percentage (F = 5.402, p = 0.002) when three factors were present. (4) Conclusions: The presence of several early risk factors related to obesity in infancy was significantly associated with higher BMI z-score and body fat percentage at 2 years of age. The presence of more than one of these variables was also associated with higher adiposity at 2 years of age. Early prevention strategies should address as many of these factors as possible.

scholarly journals Association of Non-alcoholic Fatty Liver Disease with Body Fat Percentage in Normal-Weight Individuals

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Zeynab Hatamizargaran ◽  
Mohammadreza Sasani ◽  
Masoumeh Akhlaghi
Keyword(s):  
Risk Factors ◽  
Liver Disease ◽  
Fatty Liver ◽  
Body Fat ◽  
Fatty Liver Disease ◽  
Density Lipoprotein ◽  
Normal Weight ◽  
Body Fat Percentage ◽  
Fat Percentage ◽  
Study Results

Background: Recent data have suggested that nonalcoholic fatty liver disease (NAFLD) can occur in normal-weight subjects. This study examined the association of body fat percentage (BF%) with NAFLD and its risk factors in normal-weight individuals. Objectives: The present study aimed to explain the influence of body fat on the risk of NAFLD. Methods: A total of 59 subjects with body mass index (BMI) within the range of 18.5 - 24.9 kg/m2 were selected from referrals to two major university polyclinics in Shiraz, Iran, from April to June 2019. Fatty liver grade, anthropometric characteristics, body composition, and cardiometabolic risk factors were measured in this study. Results: Waist circumference (P = 0.012), fat mass (P < 0.001), triglycerides (TG) (P = 0.027), very-low-density lipoprotein (VLDL) (P = 0.007), and TG/high-density lipoprotein cholesterol (HDL-C) ratio (P = 0.003) increased; however, skeletal muscle mass decreased (P < 0.001) across the tertiles of BF%. The average of fatty liver grade was similar in the first and second tertiles; nevertheless, the fatty liver grade of participants in the third tertile was significantly higher (1.3 ± 0.9 vs. 0.4 ± 0.7; P = 0.005). In ordinal regression analysis, BF% (1.13; 95% CI: 1.04 - 1.22; P = 0.003), BMI (1.95; 95% CI: 1.02 - 3.74; P = 0.045), VLDL (1.77; 95% CI: 1.00 - 3.12; P = 0.049), and TG/HDL-C ratio (2.21; 95% CI: 1.26 - 3.86; P = 0.006) had positive associations with NAFLD; nonetheless, HDL-C (0.33; 95% CI: 0.16 - 0.67; P = 0.002) and dietary cholesterol (0.97; 95% CI: 0.95 - 0.997; P = 0.028) had inverse associations with NAFLD after the adjustments for age, gender, BMI, and physical activity. Conclusions: The results of this study suggested that within normal weight ranges, NAFLD occurs more frequently in individuals with higher BF%. In addition, BF% can be used as an important marker in NAFLD screening.

scholarly journals Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients—A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial

2021 ◽  
Vol 8 ◽  
Author(s):  
Zhang Juan ◽  
Zhang Qing ◽  
Liang Yongping ◽  
Liyuan Qian ◽  
Wei Wu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Weight ◽  
Weight Gain ◽  
Cancer Treatment ◽  
Cancer Patients ◽  
Body Fat ◽  
Breast Cancer Treatment ◽  
Body Fat Percentage ◽  
Breast Cancer Patients ◽  
Fat Percentage

Background: Docetaxel is an important chemotherapy-agent for breast cancer treatment. One of its side-effects is weight gain, which increases the all-cause mortality rate. Considering gut microbiota is one important factor for weight regulation, we hypothesized that probiotics could be potentially used to reduce the docetaxel-related weight gain in breast cancer patients.Methods: From 10/8/2018 to 10/17/2019, 100 breast cancer (Stage I-III) patients underwent four cycles of docetaxel-based chemotherapy were enrolled and randomly assigned to receive probiotics (Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis) or placebo (supplementary material of the probiotics capsule) treatment for 84 days with three capsules per time, twice/day. The primary outcome: the changes in body weight and body-fat percentage of the patients were measured by a designated physician using a fat analyzer, and the secondary outcomes: the fasting insulin, plasma glucose, and lipids were directly obtained from the Hospital Information System (HIS); The metabolites were measured using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS); The fecal microbiome was analyzed using bacterial 16S ribosomal RNA (rRNA) gene sequence. All indicators were measured 1 day before the first cycle of docetaxel-based chemotherapy and 21 days after the last cycle of docetaxel-based chemotherapy.Results: Compared with the placebo group, the probiotic group showed significantly smaller changes in body weight (Mean [SD] 0.77 [2.58] vs. 2.70 [3.08], P = 0.03), body-fat percentage (Mean [SD] 0.04 [1.14] vs. 3.86 [11.09], P = 0.02), and low density lipoprotein (LDL) (Mean [SD]−0.05[0.68] vs. 0.39 [0.58], P = 0.002). Moreover, five of the 340 detected plasma metabolites showed significant differences between the two groups. The change of biliverdin dihydrochloride (B = −0.724, P = 0.02) was inverse correlated with weight gain. One strain of the phylum and three strains of the genus were detected to be significantly different between the two groups. Also, the changes of Bacteroides (B = −0.917, P &lt; 0.001) and Anaerostipes (B = −0.894, P &lt; 0.001) were inverse correlated with the change of LDL.Conclusions: Probiotics supplement during docetaxel-based chemotherapy for breast cancer treatment may help to reduce the increase in body weight, body-fat percentage, plasma LDL, and minimize the metabolic changes and gut dysbacteriosis.Clinical Trial Registration:http://www.chictr.org.cn/showproj.aspx?proj=24294, ChiCTR-INQ-17014181.

scholarly journals Association of Sugar-Sweetened Beverage Frequency with Adiposity: Evidence from the “Children of 1997” Birth Cohort

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1015
Author(s):  
Ting Zhang ◽  
Shiu Lun Au Yeung ◽  
Man Ki Kwok ◽  
Lai Ling Hui ◽  
Gabriel Matthew Leung ◽  
...  
Keyword(s):  
Waist Circumference ◽  
Birth Cohort ◽  
Body Fat ◽  
Body Fat Percentage ◽  
Z Score ◽  
Fat Percentage ◽  
Sugar Sweetened Beverage ◽  
Waist To Hip Ratio ◽  
Sweetened Beverage ◽  
Consumption Frequency

Background: Observationally, sugar-sweetened beverage (SSB) consumption is associated with adiposity in Western children but could be confounded. We examined the association of SSB frequency with adiposity in the non-Western setting of Hong Kong. Methods: We examined the associations of SSB consumption frequency at 11 and 13 years assessed by using a food frequency questionnaire with subsequent body mass index (BMI) z-score and overweight/obesity up to 18 years using generalized estimating equations, and with waist circumference, waist-to-hip ratio, and body fat percentage at 16–19 years using linear regression in a population-representative Chinese birth cohort “Children of 1997” (n = 3628). Results: At 11 and 13 years, 6.8% and 8.2% of children respectively consumed SSB daily. Neither SSB frequency at 11 nor at 13 years was associated with subsequent BMI z-score or overweight/obesity up to 18 years, or with waist circumference, waist-to-hip ratio, or body fat percentage at 16–19 years adjusted for age, sex, socioeconomic position, health status, physical activity and other food consumption, although bias to the null from under-reporting cannot be eliminated. Conclusion: Although we cannot definitively exclude a small association of SSB frequency with adiposity, lack of association of SSB frequency with adiposity in a non-Western setting with low SSB consumption suggests that the role of SSB in adiposity appears to be minor.

scholarly journals Body surface area, height, and body fat percentage as more sensitive risk factors of cancer and cardiovascular disease

2020 ◽  
Vol 9 (12) ◽  
pp. 4433-4446 ◽  
Author(s):  
Shucheng Si ◽  
Marlvin A. Tewara ◽  
Xiaokang Ji ◽  
Yongchao Wang ◽  
Yanxun Liu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Surface Area ◽  
Body Surface Area ◽  
Body Fat ◽  
Body Surface ◽  
Body Fat Percentage ◽  
Fat Percentage

The estimation of cardiovascular risk factors by body mass index and body fat percentage in Korean male adults

Metabolism ◽  
2009 ◽  
Vol 58 (6) ◽  
pp. 765-771 ◽  
Author(s):  
Young Gyu Cho ◽  
Hong Ji Song ◽  
Jin Myoung Kim ◽  
Kyung Hee Park ◽  
Yu Jin Paek ◽  
...  
Keyword(s):  
Risk Factors ◽  
Body Mass Index ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Body Mass ◽  
Body Fat ◽  
Body Fat Percentage ◽  
Fat Percentage

scholarly journals Effects of Fresh Mango Consumption on Blood Glucose, Insulin, and Other Cardiovascular Disease Risk Factors in Overweight and Obese Adults

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 366-366
Author(s):  
Martin Jr Rosas ◽  
Sherry Pinneo ◽  
Celeste O'Mealy ◽  
Changqi Liu ◽  
Mark Kern ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Body Weight ◽  
Liver Function ◽  
Body Fat ◽  
Disease Risk ◽  
Lipid Profiles ◽  
Body Fat Percentage ◽  
Fat Percentage ◽  
Obese Adults

Abstract Objectives Mangos contain many beneficial dietary compounds including vitamins, minerals, fiber, and are a unique source of certain polyphenols such as mangiferin. Accumulating evidence from in vitro and animal studies have demonstrated that mangos may have antidiabetic, anti-inflammatory, and cardioprotective properties. However, the effects of fresh mango consumption in humans are less clear. The objective of this study was to examine the effects of fresh mango consumption compared to an isocaloric snack (low-fat cookies) on body weight, body fat, blood pressure, glucose, insulin, lipid profiles, liver function enzymes, inflammation, and antioxidant activity in overweight and obese adults. Methods In a randomized crossover design, 27 overweight and obese adults (11 females, 16 males, age 26 ± 8.1 years) consumed 100 Kcal of fresh mangos (166g) or isocaloric low-fat cookies (24g) daily for 12 weeks. Following an overnight fast, a venous blood draw was taken at baseline, week 4, and week 12. Blood samples were analyzed for glucose, insulin, lipid profiles, liver function enzymes, C-reactive protein (CRP), and total antioxidant capacity (TAC). At each visit, body weight, body fat percentage, and blood pressure were measured. Results Twelve weeks of daily mango consumption significantly decreased blood glucose, CRP, and aspartate transaminase (AST) activity while TAC significantly increased (P &lt; 0.05). There were no significant changes in body weight, body fat percentage, blood pressure, insulin, lipid profile, or other liver function enzymes following mango consumption. Cookie consumption significantly increased insulin, CRP, and triglycerides (P &lt; 0.05). Conclusions Mango consumption improved certain chronic disease risk factors including reductions in fasting glucose and inflammation while lipid profiles and anthropometric measurements were not affected. These results suggest that relative to the control snack, daily mango consumption may improve certain risk factors associated with overweight and obesity and should be considered for future research as they contain unique bioactive compounds. Funding Sources This study was funded by the National Mango Board.

Expanded normal weight obesity and blood pressure in Chinese adults: a community-based cross-sectional study

2019 ◽  
Vol 25 (3) ◽  
pp. 256 ◽  
Author(s):  
Huijing He ◽  
Li Pan ◽  
Feng Liu ◽  
Jingang Ma ◽  
Zhiping Hu ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Body Fat ◽  
Normal Weight ◽  
Shaanxi Province ◽  
High Risk Population ◽  
Body Fat Percentage ◽  
Fat Percentage ◽  
Cross Sectional ◽  
Increased Risk ◽  
Normal Weight Obesity

The study aimed to explore the independent association between expanded normal weight obesity categories and blood pressure among adults aged 20–80 years in China. By cross-sectional design, a total of 4279 adults living in Shaanxi Province, China, were selected from communities via multi-stage stratified cluster sampling in 2014. Information on anthropometric, body composition and blood pressure was collected and analysed. Expanded normal weight obesity (ENWO) categories were used to identify the level of bodyweight based on the combination of body mass index (BMI) and body fat percentage (BFP) categories. The age- and sex-standardised prevalence of hypertension increased within ENWO groups, from 10.12% in the underweight-low body fat group to 45.92% in the obesity-high body fat group. In under or normal weight participants, body fat percentage was found independently associated with hypertension in men, with an adjusted odds ratio of 3.69 in the fourth quartile of BFP compared with the first one. However, this effect was not observed in women. BFP was independently associated with increased risk of hypertension, especially in men. People with normal BMI should be re-identified as a high-risk population based on BFP level when it comes to hypertension prevention in primary healthcare settings.

Sign in / Sign up

Export Citation Format

Share Document